Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business
Onyx Pharmaceuticals, Inc. - SWOT Analysis

Onyx Pharmaceuticals, Inc. - SWOT Analysis - companiesandmarkets.com adds new report


Print article Print article
Refer this article Refer to a friend
© companiesandmarkets.com
2008-11-19 12:25:03 - Onyx Pharmaceuticals, Inc. - SWOT Analysis - a new market research report on http://www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Onyx-Pharmac ..

Datamonitor´s Onyx Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Onyx Pharmaceuticals (Onyx) is a biopharmaceutical company engaged in the discovery

and development of therapies that target the molecular mechanisms that cause cancer. The company’s only approved product, Nexavar (sorafenib) is marketed by its collaboration partner, Bayer HealthCare Pharmaceuticals (Bayer). Nexavar is approved in more than 70 countries for the treatment of advanced kidney cancer and in more than 40 countries for the treatment of liver cancer. The company is headquartered in Richmond, California and employs 153 people. The company did not record any revenues during the financial year (FY) ended December 2007 mainly due to the company’s collaboration partner, Bayer recognizes all revenue from the sale of Nexavar under the collaborative agreement. The operating loss of the company was $53.4 million during FY2007, as compared to an operating loss of $104.6 million in 2006. The net loss was $34.2 million in FY2007, as compared to a net loss of $92.6 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: 07813 784393

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.


Terms & Conditions | About us | Contact PR-inside.com